The Europe infertility testing & treatment market is registered to grow with a CAGR of 10.73% over the forecasting period of 2021 to 2028. Factors such as the presence of advanced healthcare facilities, the rising age of conception and late marriages, as well as the high awareness associated with infertility, are set to drive the market growth.

EUROPE INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

Europe Infertility Testing & Treatment Market by Gender ( Male (Male Infertility Testing ( Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer-assisted Semen Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others ) Male Infertility Treatment (Medication, Assisted Reproductive Technology & Varicocele Surgery)) (Female ( Female Infertility Testing ( Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others) Female Infertility Treatment ( IVF With ICSI, IUI, IVF Without ICSI, Surrogacy, Others)) Market by End-user ( Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) and by Geography.

Request free sample

The Europe infertility testing & treatment market is registered to grow with a CAGR of 10.73% over the forecasting period of 2021 to 2028. Factors such as the presence of advanced healthcare facilities, the rising age of conception and late marriages, as well as the high awareness associated with infertility, are set to drive the market growth.

europe-infertility-testing-and-treatment-marketThe Europe infertility testing & treatment market growth evaluation includes analyzing Germany, France, Italy, Belgium, the United Kingdom, Poland, Russia, and the rest of Europe. Infertility rates in the United Kingdom are continually rising. Although not a new phenomenon, infertility has observed a dramatic increase in the country over the last 60 years. As per the report published in 2019 by the Office for National Statistics (ONS), the birth rate across Wales and England reached a new low in 2018. The notable decline is mainly attributed to the plummeting fertility rates as well as the aging population.

Germany is one of the leading nations in terms of the incidence of obesity. According to the World Health Organization (WHO), obesity among adolescents and children has reached alarming percentages in the country. For instance, the statistics issued by the Organization for Economic Co-operation and Development (OECD) indicate that more than 23% of individuals in Germany were obese in 2017. The increasing rates of obesity heighten the likelihood of infertility, thereby augmenting the overall market demand. Hence, these factors are set to fuel the Europe infertility testing & treatment market growth during the forecasting years.

Vitrolife AB, headquartered in Sweden, is primarily involved with assisted reproduction services. The company’s product portfolio constitutes EmbryoGlue, a human albumin recombinant, ASP, a solution for oocyte retrieval and rinsing, G-RINSE, a solution for rinsing contact materials, Semen VTS, a viscosity treatment system, and others. It also offers a range of procedural solutions for sperm preparation, embryo transfer, and vitrification.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • GROWING STRESS AND LIFESTYLE DISORDERS
        • INCREASED AGE OF CONCEPTION
        • INCREASING EFFECTIVENESS OF TREATMENTS
        • RISING GOVERNMENT SUPPORT
      • KEY RESTRAINTS
        • HIGH COST OF TESTING AND TREATMENT
        • INFERTILITY CONSIDERED A SOCIAL TABOO
        • POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END-USERS
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • ADORFEM
        • BANGKOK IVF CENTER
        • COOK MEDICAL INC
        • COOPER SURGICAL
        • CREATE FERTILITY CENTRE
        • EMD GROUP (MERCK KGAA)
        • ENDO INTERNATIONAL PLC
        • ESCO MEDICAL
        • FERRING PHARMACEUTICALS
        • FERTILITY FIRST
        • FUJIFILM IRVINE SCIENTIFIC
        • GENEA LTD
        • HALOTECH DNA
        • HAMILTON THRONE LTD
        • IVFTECH
        • LABOTECT GMBH
        • OLYMPUS CORPORATION
        • PROGYNY
        • THERMO FISHER SCIENTIFIC INC
        • VITROLIFE AB

     

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT

    TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

    TABLE 3: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: PROS AND CONS OF DNA SHARING METHODS

    TABLE 10: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 21: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 22: LIST OF MERGERS & ACQUISITIONS

    TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS

     

    LIST OF FIGURES                                                                

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: KEY BUYING CRITERIA

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 8: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020

    FIGURE 10: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 12: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

    FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION

    FIGURE 14: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 22: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

    FIGURE 25: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020

    FIGURE 26: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020

    FIGURE 28: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

    FIGURE 30: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

    FIGURE 31: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

    FIGURE 32: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 33: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 34: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 35: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 36: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020

    FIGURE 37: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 38: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

    FIGURE 39: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 40: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

    FIGURE 41: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 42: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 43: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 44: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

    FIGURE 45: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

    FIGURE 46: EUROPE INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 47: UNITED KINGDOM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: GERMANY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: FRANCE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 50: ITALY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 51: RUSSIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 52: BELGIUM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 53: POLAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 54: REST OF EUROPE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type